ENTA ENANTA PHARMACEUTICALS INCcompanySEC Filings & Insider Trading Activity 2026
Latest ENANTA PHARMACEUTICALS INC (ENTA) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on November 19, 2025, a 10-Q quarterly report filed on May 13, 2026, an 8-K current report filed on July 2, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for ENANTA PHARMACEUTICALS INC (ENTA) (SEC CIK 1177648), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Go deeper on ENANTA PHARMACEUTICALS INC
Ask AI about ENTA filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.
Track institutional money. See which funds are building or cutting ENTA positions, quarter over quarter.
Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on ENTA.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of ENANTA PHARMACEUTICALS INC (ENTA) 8-K current reports disclosing material events.
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Jul 2, 2026 | - | - | - |
8-K | Jun 23, 2026 | - | - | - |
8-K | Jun 18, 2026 | - | - | - |
10-Q | May 13, 2026 | Mar 31, 2026 | - | |
8-K | May 11, 2026 | - | - | |
8-K | Mar 26, 2026 | - | - | - |
8-K | Mar 12, 2026 | - | Analysis | - |
10-Q | Feb 11, 2026 | Dec 31, 2025 | - | |
8-K | Feb 9, 2026 | - | - | |
10-K | Nov 19, 2025 | Sep 30, 2025 | - | |
10-Q | Aug 13, 2025 | Jun 30, 2025 | - | |
10-Q | May 14, 2025 | Mar 31, 2025 | - | |
10-Q | Feb 12, 2025 | Dec 31, 2024 | - | |
10-K | Nov 27, 2024 | Sep 30, 2024 | - | |
10-Q | Aug 7, 2024 | Jun 30, 2024 | - | |
10-Q | May 8, 2024 | Mar 31, 2024 | - | |
10-Q | Feb 8, 2024 | Dec 31, 2023 | - | |
SC 13G | Jan 11, 2024 | - | - | |
10-K | Nov 22, 2023 | Sep 30, 2023 | - | |
SC 13G | Nov 16, 2023 | - | - | |
10-Q | Aug 8, 2023 | Jun 30, 2023 | - | |
10-Q | May 9, 2023 | Mar 31, 2023 | - | |
SC 13G | Feb 14, 2023 | - | - | |
10-Q | Feb 8, 2023 | Dec 31, 2022 | - | |
SC 13G | Jan 31, 2023 | - | - |
13F Fund Holdings: Quarterly Trend
Latest: Q1 2026Aggregate ENTA share value held by 13F filers tracked by SignalX, by quarter.
- Millennium Management+211.7K (+32%)
- Citadel Advisors LLC+181.9K (+163%)
- AQR Capital Management+78.3K (+33%)
- Goldman Sachs Group+46.3K (+21%)
- State Street Corp+38.4K (+7%)
- D.E. Shaw & Co96.8K (-58%)
- Bank of America Corp39.4K (-60%)
- Morgan Stanley30.4K (-9%)
- Wells Fargo & Co20.3K (-66%)
- Two Sigma Investments18.1K (-6%)
- Franklin Resources+66.9K
- Fifth Third Bancorp+367
- Vanguard Group Inc−2.30M
- Invesco Ltd−253.8K
- JPMorgan Chase & Co−113.0K
Source: 13F-HR filings on SEC EDGAR (aggregated from 163 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.
Frequently Asked Questions
What are the latest ENTA SEC filings in 2026?
ENANTA PHARMACEUTICALS INC (ENTA) has filed a 10-K annual report on November 19, 2025, a 10-Q quarterly report on May 13, 2026, an 8-K current report on July 2, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did ENTA file its most recent 10-K annual report?
ENANTA PHARMACEUTICALS INC (ENTA) filed its most recent 10-K annual report on November 19, 2025. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view ENTA 10-Q quarterly reports?
ENANTA PHARMACEUTICALS INC (ENTA)'s most recent 10-Q quarterly report was filed on May 13, 2026. SignalX displays every ENTA 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has ENTA filed recently?
ENANTA PHARMACEUTICALS INC (ENTA)'s most recent 8-K was filed on July 2, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find ENTA insider trading activity (Form 4)?
SignalX aggregates every ENTA Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does ENTA file with the SEC?
ENANTA PHARMACEUTICALS INC (ENTA) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new ENTA filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for ENANTA PHARMACEUTICALS INC (ENTA).
What is ENTA's SEC CIK number?
ENANTA PHARMACEUTICALS INC (ENTA)'s SEC CIK (Central Index Key) number is 1177648. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1177648 to look up all ENTA filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Stay on top of ENANTA PHARMACEUTICALS INC SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 89+ filings.